Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer

British Journal of Cancer

Volumn 78, Issue 8, 1998, Pages 1018-1023

  Lahm, H ^a   Schindel, M ^b   Frikart, L ^c   Cerottini, J P ^c   Yilmaz, A ^d   Givel, J C ^c   Fischer, J R ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Thoraxklinik der LVA Baden   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Centre Pluridisciplinaire d'Oncologie   (Switzerland)

Author keywords

Colorectal cancer; Cytokine secretion; Lymphocyte depletion; Whole blood cell culture

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 0031715775     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.621     Document Type: Article

References (28)

1. Bang KM and Laing CA (1986) Lymphocytopenia in high cancer risk population: evidence in automobile pattern makers. Cancer Lett 30: 311-314
2. Billings KR, Wang MB and Lichtenstein AK (1997) Suppressive factor or factors derived from head and neck squamous cell carcinoma induce apoptosis in activated lymphocytes. Otolaryngol Head and Neck Surg 116: 458-465
3. Bodmer S, Strommer K, Frei K, Siepl C, de Tribolet N, Heid I and Fontana A (1989) Immunosuppression and transforming growth factor β in glioblastoma. Preferential production of transforming growth factor β2. J Immunol 143: 3222-3229
4. De Groote D, Gevaert Y, Lopez M, Gathy R, Marchal F, Detroz B, Jacquet N and Geenen V (1996) Ex vivo cytokine production by whole blood cells from cancer patients. Cancer Detect Prev 20: 207-213
5. Ebert EC, Roberts AI, Devereux D and Nagase H (1990) Selective immunosuppressive action of a factor produced by colon cancer cells. Cancer Res 50: 6158-6161
6. Elsässer-Beile U, von Kleist S and Gallati H (1991) Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J Immunol Methods 139: 191-195
7. Elsässer-Beile U, von Kleist S, Fischer R and Schulte Mönting J (1992) Impaired cytokine production from whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J Clin Lab Anal 6: 311-314
8. Elsässer-Beile U, von Kleist S, Sauther W, Gallati H and Schulte Mönting J (1993a) Impaired cytokine production in whole blood cells of patients with gynaecological carcinomas in different clinical stages. Br J Cancer 68: 32-36
9. Elasässer-Beile U, von Kleist S, Fischer R, Wetterauer U, Gallati H and Schulte Mönting J (1993b) Impaired cytokine production in whole blood cell cultures of patients with urological carcinomas. J Cancer Res Clin Oncol 119: 430-433
10. 1 by small cell lung cancer cell lines. Eur J Cancer 30A: 2125-2129
11. Fischer JR, Schindel M, Stein N, Lahm H, Gallati H, Krammer PH and Drings P (1995) Selective suppression of cytokine secretion in patients with small-cell lung cancer. Ann Oncol 6: 921-926
12. Fischer JR, Schindel M, Bülzebruck H, Lahm H, Krammer PH and Drings P (1997) Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer. Ann Oncol 8: 457-461
13. Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, Chen M, Albino AP and Bander NH (1993) Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55: 96-101
14. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J and Tschopp J (1996) Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363-1366
15. Herfarth HH, Mohanty SP, Rath HC, Tonkonogy S and Sartor RB (1996) Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 39: 836-845
16. Hersey P, Bindon C, Czerniecki M, Spurling A, Wass J and McCarthy WH (1983) Inhibition of interleukin 2 production by factors released from tumor cells. J Immunol 131: 2837-2842
17. Ikeda T, Masuno T, Ogura T, Watanabe M, Shirasaka T, Hara H, Tanio Y, Kawase I and Kishimoto S (1991) Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line. Jpn J Cancer 82: 332-338
18. Lahm H and Odartchenko N (1993) Role of transforming growth factor β in colorectal cancer. Growth Factors 9: 1-9
19. Li JM, Isler P, Dayer JM and Burger D (1995) Contact-dependent stimulation of monocytic cells and neutrophils by stimulated human T-cell clones. Immunology 84: 571-576
20. Neustock P, Brand JM, Kruse A and Kirchner H (1993) Cytokine production of the human monocytic cell line Mono Mac 6 in comparison to mature monocytes in peripheral blood mononuclear cells. Immunobiol 188: 293-302
21. O' Connell J, O'Sullivan GC, Collins JK and Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184: 1075-1082
22. O' Sullivan GC, Corbett AR, Shanahan F and Collins JK (1996) Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes. J Immunol 157: 4717-4720
23. Rey A, Klein B, Zaguri D, Thierry C and Serrou B (1983) Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells. Immunol Lett 6: 175-178
24. Robins TG, Weinstein RJ and Demers RY (1991) Lymphocytopenia, T-lymphocyte subsets, and colorectal polys in automotive pattern and model makers. J Occup Med 33: 510-515
25. Shiraki K, Tsuji N, Shioda T, Isselbacher KJ and Takahashi H (1997) Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci USA 94: 6420-6425
26. Wanebo HJ, Rao B, Attiyeh F, Pinsky C, Middleman P and Stearns M (1980) Immune reactivity in patients with colorectal cancer: assessment of biological risk by immune parameters. Cancer 45: 1254-1263
27. Yoshino I, Yano T, Murata M, Ishida T, Sugimachi K, Kimura G and Nomoto K (1992) Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res 52: 775-781
28. Yoshino I, Yano T, Miyamoto M, Yamada K, Kajii Y, Onodera K, Ishida T, Sugimachi K, Kimura G and Nomoto K (1993) Characterization of lung squamous cell carcinoma-derived T-cell suppressive factor. Cancer 72: 2347-2357